Figee M, Riva-Posse P, Choi KS, Bederson L, Mayberg HS, Kopell BH. Deep brain stimulation for depression. Neurotherapeutics. 2022;19:1229–45.

Article  PubMed  PubMed Central  Google Scholar 

Holtzheimer PE, Mayberg HS. Deep brain stimulation for psychiatric disorders. Annu Rev Neurosci. 2011;34:289–307.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, et al. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45:651–60.

Article  CAS  PubMed  Google Scholar 

Weigand A, Horn A, Caballero R, Cooke D, Stern AP, Taylor SF, et al. Prospective validation that subgenual connectivity predicts antidepressant efficacy of transcranial magnetic stimulation sites. Biol Psychiatry. 2018;84:28–37.

Article  CAS  PubMed  Google Scholar 

Herrera-Melendez A-L, Bajbouj M, Aust S. Application of transcranial direct current stimulation in psychiatry. Neuropsychobiology. 2020;79:372–83.

Article  PubMed  Google Scholar 

Moffa AH, Brunoni AR, Nikolin S, Loo CK. Transcranial direct current stimulation in psychiatric disorders: a comprehensive review. Psychiatr Clin North Am. 2018;41:447–63.

Article  PubMed  Google Scholar 

Riis TS, Feldman DA, Vonesh LC, Brown JR, Solzbacher D, Kubanek J, et al. Durable effects of deep brain ultrasonic neuromodulation on major depression: a case report. J Med Case Rep. 2023;17:449.

Riva-Posse P, Choi KS, Holtzheimer PE, McIntyre CC, Gross RE, Chaturvedi A, et al. Defining critical white matter pathways mediating successful subcallosal cingulate deep brain stimulation for treatment-resistant depression. Biol Psychiatry. 2014. https://doi.org/10.1016/j.biopsych.2014.03.029.

Cole EJ, Phillips AL, Bentzley BS, Stimpson KH, Nejad R, Barmak F, et al. Stanford Neuromodulation Therapy (SNT): a double-blind randomized controlled trial. Am J Psychiatry. 2022;179:132–41.

Article  PubMed  Google Scholar 

Baldermann JC, Schüller T, Kohl S, Voon V, Li N, Hollunder B, et al. Connectomic deep brain stimulation for obsessive-compulsive disorder. Biol Psychiatry. 2021;90:678–88.

Article  CAS  PubMed  Google Scholar 

Crowell AL, Riva-Posse P, Holtzheimer PE, Garlow SJ, Kelley ME, Gross RE, et al. Long-term outcomes of subcallosal cingulate deep brain stimulation for treatment-resistant depression. Am J Psychiatry. 2019;176:949–56.

Article  PubMed  Google Scholar 

Holtzheimer PE, Husain MM, Lisanby SH, Taylor SF, Whitworth LA, McClintock S, et al. Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial. Lancet Psychiatry. 2017;4:839–49.

Article  PubMed  Google Scholar 

Kopell B, Himes L, Ross E, Mayberg H. ID: 221667 lessons in BROADEN and since BROADEN: the long and winding path to FDA breakthrough designation. Neuromodulation. 2023;26:S5.

Article  Google Scholar 

Johansen-Berg H, Gutman DA, Behrens TE, Matthews PM, Rushworth MF, Katz E, et al. Anatomical connectivity of the subgenual cingulate region targeted with deep brain stimulation for treatment-resistant depression. Cereb Cortex. 2008;18:1374–83.

Article  CAS  PubMed  Google Scholar 

Riva-Posse P, Choi KS, Holtzheimer PE, Crowell AL, Garlow SJ, Rajendra JK, et al. A connectomic approach for subcallosal cingulate deep brain stimulation surgery: prospective targeting in treatment-resistant depression. Mol Psychiatry. 2017. https://doi.org/10.1038/mp.2017.59.

Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA, et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry. 1999;156:675–82.

Article  CAS  PubMed  Google Scholar 

Sale MV, Mattingley JB, Zalesky A, Cocchi L. Imaging human brain networks to improve the clinical efficacy of non-invasive brain stimulation. Neurosci Biobehav Rev. 2015;57:187–98.

Article  PubMed  Google Scholar 

Rudebeck PH, Rich EL, Mayberg HS. From bed to bench side: reverse translation to optimize neuromodulation for mood disorders. Proc Natl Acad Sci USA. 2019;116:2688–96.

Denys D, Mantione M, Figee M, van den Munckhof P, Koerselman F, Westenberg H, et al. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Arch Gen Psychiatry. 2010;67:1061–8.

Article  PubMed  Google Scholar 

Williams NR, Sudheimer KD, Cole EJ, Varias AD, Goldstein-Piekarski AN, Stetz P, et al. Accelerated neuromodulation therapy for obsessive-compulsive disorder. Brain Stimul. 2021;14:435–7.

Article  PubMed  PubMed Central  Google Scholar 

Gault JM, Davis R, Cascella NG, Saks ER, Corripio-Collado I, Anderson WS, et al. Approaches to neuromodulation for schizophrenia. J Neurol Neurosurg Psychiatry. 2018;89:777–87.

Article  PubMed  Google Scholar 

Hensel L, Lüdtke J, Brouzou KO, Eickhoff SB, Kamp D, Schilbach L. Noninvasive brain stimulation in autism: review and outlook for personalized interventions in adult patients. Cereb Cortex. 2024;34:8–18.

Article  PubMed  Google Scholar 

Mehta DD, Praecht A, Ward HB, Sanches M, Sorkhou M, Tang VM, et al. A systematic review and meta-analysis of neuromodulation therapies for substance use disorders. Neuropsychopharmacology. 2024;49:649–80.

Article  PubMed  Google Scholar 

Jensen MP, Day MA, Miró J. Neuromodulatory treatments for chronic pain: efficacy and mechanisms. Nat Rev Neurol. 2014;10:167–78.

Article  PubMed  PubMed Central  Google Scholar 

Knotkova H, Hamani C, Sivanesan E, Le Beuffe MFE, Moon JY, Cohen SP, et al. Neuromodulation for chronic pain. Lancet. 2021;397:2111–24.

Article  PubMed  Google Scholar 

Denison T, Morrell MJ. Neuromodulation in 2035: the neurology future forecasting series. Neurology. 2022;98:65–72.

Article  PubMed  PubMed Central  Google Scholar 

Wiseman M, Sewell IJ, Nestor SM, Giacobbe P, Hamani C, Lipsman N, et al. Cognitive effects of focal neuromodulation in neurological and psychiatric disorders. Nat Rev Psychol. 2024;3:242–60.

Article  Google Scholar 

Friedrich MJ. Depression is the leading cause of disability around the World. JAMA. 2017;317:1517.

PubMed  Google Scholar 

Zhdanava M, Pilon D, Ghelerter I, Chow W, Joshi K, Lefebvre P, et al. The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States. J Clin Psychiatry. 2021;82:20m13699.

Article  PubMed  Google Scholar 

Thomas L, Kessler D, Campbell J, Morrison J, Peters TJ, Williams C, et al. Prevalence of treatment-resistant depression in primary care: cross-sectional data. Br J Gen Pract. 2013;63:e852–858.

Article  PubMed  PubMed Central  Google Scholar 

Drevets WC, Raichle ME. Neuroanatomical circuits in depression: implications for treatment mechanisms. Psychopharmacol Bull. 1992;28:261–74.

CAS  PubMed  Google Scholar 

Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 1997;386:824–7.

Article  CAS  PubMed  Google Scholar 

Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL, et al. Cingulate function in depression: a potential predictor of treatment response. Neuroreport. 1997;8:1057–61.

Article  CAS  PubMed  Google Scholar 

Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S, et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry. 2000;48:830–43.

Article  CAS  PubMed  Google Scholar 

Keedwell PA, Andrew C, Williams SC, Brammer MJ, Phillips ML. The neural correlates of anhedonia in major depressive disorder. Biol Psychiatry. 2005;58:843–53.

Article  PubMed  Google Scholar 

Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry. 2009;66:407–14.

Article  PubMed  PubMed Central